Prospective, multicenter validation of a clinical risk score for left atrial arrhythmogenic substrate based on voltage analysis: DR-FLASH score

Heart Rhythm

Volumn 12, Issue 11, 2015, Pages 2207-2212

  Kosiuk, Jedrzej ^a   Dinov, Borislav ^a   Kornej, Jelena ^a   Acou, Willem Jan ^b   Schönbauer, Robert ^c   Fiedler, Lukas ^c   Buchta, Piotr ^d   Myrda, Krzysztof ^d   Gąsior, Mariusz ^d   Poloński, Lech ^d   Kircher, Simon ^a   Arya, Arash ^a   Sommer, Philipp ^a   Bollmann, Andreas ^a   Hindricks, Gerhard ^a   Rolf, Sascha ^a  

^a UNIVERSITY OF LEIPZIG HEART CENTER   (Germany)

^b AZ Delta ^*  (Belgium)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Ablation; Atrial fibrillation; Fibrosis; Outcome; Score

Indexed keywords

ADULT; AGED; ARRHYTHMOGENESIS; ARTICLE; ATRIAL FIBRILLATION; CARDIAC MAPPING SYSTEM; CATHETER ABLATION; DR FLASH SCORE; ELECTRIC POTENTIAL; FEMALE; HEART LEFT ATRIUM; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY VEIN ISOLATION; SCORING SYSTEM; VALIDATION STUDY; ACTION POTENTIAL; BODY SURFACE POTENTIAL MAPPING; BRUGADA SYNDROME; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; FOLLOW UP; HEART ATRIUM; HEART FUNCTION TEST; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; SURVIVAL RATE; TREATMENT OUTCOME;

ACTION POTENTIALS; AGED; ATRIAL FIBRILLATION; BODY SURFACE POTENTIAL MAPPING; BRUGADA SYNDROME; CATHETER ABLATION; COHORT STUDIES; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; FEMALE; FOLLOW-UP STUDIES; HEART ATRIA; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; ROC CURVE; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84945443403     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2015.07.003     Document Type: Article

References (20)

1. H. Calkins, K.H. Kuck, R. Cappato, and et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation: developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS): endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society Heart Rhythm 9 2012 632 696
2. C. Mahnkopf, T.J. Badger, N.S. Burgon, M. Daccarett, T.S. Haslam, C.T. Badger, C.J. McGann, N. Akoum, E. Kholmovski, R.S. Macleod, and N.F. Marrouche Evaluation of the left atrial substrate in patients with lone atrial fibrillation using delayed-enhanced MRI: implications for disease progression and response to catheter ablation Heart Rhythm 7 2010 1475 1481
3. R.S. Oakes, T.J. Badger, E.G. Kholmovski, and et al. Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation Circulation 119 2009 1758 1767
4. A. Verma, O.M. Wazni, N.F. Marrouche, and et al. Pre-existent left atrial scarring in patients undergoing pulmonary vein antrum isolation: an independent predictor of procedural failure J Am Coll Cardiol 45 2005 285 292
5. B. Dinov, J. Kosiuk, S. Kircher, A. Bollmann, W.J. Acou, A. Arya, G. Hindricks, and S. Rolf Impact of metabolic syndrome on left atrial electroanatomical remodeling and outcomes after radiofrequency ablation of nonvalvular atrial fibrillation Circ Arrhythm Electrophysiol 7 2014 483 489
6. X.H. Wang, Z. Li, J.L. Mao, and B. He A novel individualized substrate modification approach for the treatment of long-standing persistent atrial fibrillation: preliminary results Int J Cardiol 175 2014 162 168
7. N.F. Marrouche, D. Wilber, G. Hindricks, and et al. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study JAMA 311 2014 498 506
8. S. Rolf, S. Kircher, A. Arya, C. Eitel, P. Sommer, S. Richter, T. Gaspar, A. Bollmann, D. Altmann, C. Piedra, G. Hindricks, and C. Piorkowski Tailored atrial substrate modification based on low-voltage areas in catheter ablation of atrial fibrillation Circ Arrhythm Electrophysiol 7 2014 825 833
9. G.Y. Lip, R. Nieuwlaat, R. Pisters, D.A. Lane, and H.J. Crijns Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation Chest 137 2010 263 272
10. R.M. Lang, M. Bierig, R.B. Devereux, and et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463
11. P. Sanders, J.B. Morton, N.C. Davidson, S.J. Spence, J.K. Vohra, P.B. Sparks, and J.M. Kalman Electrical remodeling of the atria in congestive heart failure: electrophysiological and electroanatomic mapping in humans Circulation 108 2003 1461 1468
12. P.M. Kistler, P. Sanders, S.P. Fynn, I.H. Stevenson, S.J. Spence, J.K. Vohra, P.B. Sparks, and J.M. Kalman Electrophysiologic and electroanatomic changes in the human atrium associated with age J Am Coll Cardiol 44 2004 109 116
13. C. Eitel, G. Hindricks, P. Sommer, and et al. Circumferential pulmonary vein isolation and linear left atrial ablation as a single-catheter technique to achieve bidirectional conduction block: the pace-and-ablate approach Heart Rhythm 7 2010 157 164
14. H. Calkins Catheter ablation to maintain sinus rhythm Circulation 125 2012 1439 1445
15. A. Fürnkranz, S. Bordignon, B. Schmidt, M. Gunawardene, B. Schulte-Hahn, V. Urban, F. Bode, B. Nowak, and J.K. Chun Improved procedural efficacy of pulmonary vein isolation using the novel second-generation cryoballoon J Cardiovasc Electrophysiol 24 2013 492 497
16. T. Deneke, A. Schade, P. Müller, R. Schmitt, G. Christopoulos, J. Krug, G. Szöllösi, A. Mügge, S. Kerber, and K. Nentwich Acute safety and efficacy of a novel multipolar irrigated radiofrequency ablation catheter for pulmonary vein isolation J Cardiovasc Electrophysiol 25 2014 339 345
17. C. Pappone, G. Augello, S. Sala, and et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study J Am Coll Cardiol 48 2006 2340 2347
18. A. Cheema, J. Dong, D. Dalal, and et al. Long-term safety and efficacy of circumferential ablation with pulmonary vein isolation J Cardiovasc Electrophysiol 17 2006 1080 1085
19. Verma A, Jiang C-Y, Betts TR, Chen J, Deisenhofer I, Mantovan R, Macle L, Morillo C, Sanders P. Optimal method and outcomes of catheter ablation of persistent atrial fibrillation: results of the prospective, randomized STAR AF 2 trial. Abstract presented at: ECS Congress 2014; September 1, 2014; Barcelona, Spain. http://www.escardio.org/Congresses-&-Events/Congress-resources/ESC-Congress-365/Optimal-method-and-outcomes-of-catheter-ablation-of-persistent-atrial-fibrillati. Accessed July 27, 2015.
20. K.S. Coyne, C. Paramore, S. Grandy, M. Mercader, M. Reynolds, and P. Zimetbaum Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States Value Health 9 2006 348 356